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Abstract
The inability of conventional identiﬁcation systems to accurately identify Gordonia spp. often results in the misdiagnosis of infections by
these rare pathogens, which require genomic sequencing for precise identiﬁcation. In the present study, we describe nine cases of the
various types of infection caused by Gordonia spp. From 1997 to 2008, 66 isolates (from 30 patients) initially identiﬁed as Rhodoccus spp.
by conventional biochemical methods, by the Bacteriology Laboratory of National Taiwan University Hospital, were retrospectively anal-
ysed to assess the accuracy of species identiﬁcation. Fifteen of these isolates (from nine patients) were later found to be Gordonia spp.
by two molecular methods: PCR-restriction fragment length polymorphism for heat shock protein gene (hsp65) and the 16S rRNA gene
sequencing analysis. Gordonia sputi (n = 8) was the most common species, followed by Gordonia terrae (n = 7). Most of the isolates were
isolated from blood (n = 11), followed by soft tissue (n = 2) and eye (n = 2). Five patients presented with bacteraemia and two of these
had catheter-related bloodstream infection. Two patients had soft tissue infections and another two patients had infective keratitis and
conjunctivitis. The random ampliﬁed polymorphic DNA patterns for isolates from different patients were different, indicating that they
were genetically unrelated. Accurate identiﬁcation with molecular methods is required if the role of Gordonia spp. in causing infection is
to be recognized.
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Introduction
Gordonia spp., previously classiﬁed as Rhodococcus spp., are
ubiquitous in the environment, and often are found in soil
and water. Five Gordonia spp, Gordonia terrae, Gordonia bron-
chialis, Gordonia polyisoprenivorans, Gordonia sputi and Gordonia
otitidis, have been implicated rarely as a cause of human infec-
tions [1–5] in both immunocompromised and immunocom-
petent patients. The limited number of reported cases
included central venous catheter-related bloodstream
infection, endocarditis, brain abscess and cutaneous infection
[1–12]. Three to four days were required to isolate the
bacterium, owing to its slow growth. This delay may lead to
false negative results and an underestimation of the incidence
of infection caused by this genus. In addition, the inability of
readily available identiﬁcation systems to accurately identify
Gordonia spp. leads to further difﬁculties. Precise identiﬁca-
tion of these microorganisms requires genomic sequencing, a
method that is unavailable in most clinical laboratories. These
problems, along with the difﬁculty of determining whether
environmental bacteria are pathogens when they are isolated
from human specimens, may contribute to the underdiagno-
sis of Gordonia spp. infections.
A better understanding of the epidemiology and clinical
characteristics of infections caused by these environmental
or opportunistic pathogens is needed. In the present
study, we describe nine cases of the various types of
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infections caused by Gordonia spp., all of which were ini-
tially misidentiﬁed as Rhodococcus spp.
Materials and Methods
Hospital setting and patient selection
National Taiwan University Hospital is a 2500-bed, academi-
cally afﬁliated medical centre providing both primary and
tertiary care in northern Taiwan. A total of 66 isolates iden-
tiﬁed as Rhodococcus spp. by the Clinical Bacteriology Labora-
tory of National Taiwan University Hospital from January
1997 to June 2008 were preserved for further investigation.
Those ultimately identiﬁed as Gordonia spp. deﬁned the
patients for inclusion. The clinical charts of all patients were
retrospectively reviewed. Information on age, gender, under-
lying conditions, treatment and outcome was recorded.
Catheter-related bacteraemia (CRBSI) was deﬁned as the
presence of bacteraemia and clinical manifestations of infec-
tion (i.e. fever, chills and/or hypotension) in a patient with an
intravenous catheter, and no apparent source for the blood-
stream infection except the catheter. Skin and soft-tissue
infection (SSTI) caused by Gordonia spp. was deﬁned as
clinical soft tissue inﬂammation with positive culture for
Gordonia spp. alone. If no primary focus could be identiﬁed,
the bacteraemia was classiﬁed as primary.
Bacterial isolates
A total of 66 isolates (from 39 patients) initially identiﬁed as
Rhodococcus spp. during the study period were subjected to
further testing to detect Gordonia spp., by conventional bio-
chemical and two molecular methods. Initial identiﬁcation of
Gordonia spp. was based on Gram-stained appearances
(Gram-positive coryneform bacilli), colonial morphology and
conventional biochemical reactions, including hydrolysis of
casein, xanthine, hypoxanthine and tyrosine [9]. Identiﬁcation
as Gordonia spp. was conﬁrmed by two molecular methods.
The ﬁrst molecular method was a previously described PCR-
restriction fragment length polymorphism (RFLP) identiﬁca-
tion scheme that used an ampliﬁed 440-bp segment of the
65-kDa heat shock protein gene (hsp65) performed using the
two primers TB11 (5¢-ACCAACGATGGTGTGTCCAT-3¢)
and TB12 (5¢-CTTGTCGAACCGCATACCCT-3¢) [13,14]
and digestion by MspI and HinfI. The second molecular
method was 16S rRNA gene sequencing using a pair of uni-
versal primers, 8FLP (5¢-AGAGTTTGATCCTGGCTCAG-3¢)
and 1492RPL (5¢-GGTTACCTTGTTACGACTT-3¢) [13]. The
sequences (1080 bp) obtained were compared with pub-
lished sequences in the GenBank database by using the
BLASTN algorithm (http://www.ncbi.nlm.nih.gov/blast). The
accession number and closest match observed were obtained
[13,14].
Antimicrobial susceptibility testing
The MICs for the Gordonia isolates of 20 antimicrobial agents
were determined by the broth microdilution method (PMIC/
ID-30 Panel, Phoenix; Becton-Dickinson, Sparks, MD, USA)
after incubation for 48 h [15]. For Gordonia spp. there are no
MIC interpretive breakpoints of antimicrobial agents recom-
mended by the CLSI.
Random ampliﬁed polymorphic DNA (RAPD) analysis
Isolates were incubated in brain-heart infusion (Difco Labora-
tories, Detroit, MI, USA) for 36–48 h at 35C in ambient air.
Bacterial genomic DNA was extracted by using a commercial
kit (Puregene; Gentra Systems, Inc., Minneapolis, MN, USA).
The RAPD assay, generated by arbitrarily primed PCR (AP-
PCR), was performed using two arbitrary oligonucleotide
primers: M13 (5¢-TTATGTAAAACGACGGCCAGT-3¢) and
H4 (5¢-GGAAGTCGCC-3¢) (OPERON Technologies, Inc.,
Alameda, CA, USA). The conditions for PCR were in accor-
dance with those used in a previous study [16].
Results
Microbiological investigations
Among the 66 isolates initially identiﬁed as Rhodococcus spp.
by conventional biochemical methods during the 11-year
study period, 15 isolates from nine patients were identiﬁed
as Gordonia spp. by PCR-RFLP of hsp65 and 16S rRNA gene
sequencing (Table 1). The unique fragments of the isolates
digested by HinfI (245/150 bp for Gordonia spp.) and MspI
(180/130 for G. terrae and 440 for G. sputi) identiﬁed these
two Gordonia spp. [14]. Two patients had three and ﬁve Gor-
donia isolates, respectively. G. sputi (n = 8) was the most
common pathogen, followed by G. terrae (n = 7). Most of the
isolates were from blood (n = 11, from ﬁve patients), fol-
lowed by soft tissue (n = 2, from two patients) and cornea
(n = 2, from two patients).
Clinical characteristics
The clinical characteristics of the nine patients with Gordonia
infection are summarized in Table 1. The patients were in
the age range 13–75 years, and six of the nine patients were
male. Eight patients had various underlying diseases but the
other patient did not have any evidence of comorbidity. Five
patients presented with bacteraemia and two of them had
catheter-related bloodstream infection. Although transo-
esophageal echocardiography was not performed in three
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bacteraemia patients, primary bacteraemia was diagnosed in
these patients because they showed no murmur or
peripheral stigmata of endocarditis. All outcomes were
favourable despite variation in the antibiotic regimens. Bac-
teraemia in one patient (patient 1) with CRBSI (Port-A Cath)
as a result of G. terrae lasted for 4 months despite prolonged
antibiotic use, including vancomycin, imipenem and intrave-
nous ciproﬂoxacin. The infection resolved after subsequent
removal of the Port-A Cath 4 months later. By contrast, the
catheter was not removed in patient 8 with persistent CRBSI
as a result of G. sputi under management with systemic anti-
microbial agents and antibiotic lock therapy with amikacin.
One patient had G. terrae-related cellulitis and improved after
treatment with amoxicillin/clavulanate. Another patient had
traumatic wound infection as a result of G. terrae and was
successfully managed with repeated surgical debridement and
treatment with amoxicillin/clavulanate. In addition, corneal
culture grew G. sputi alone in a newborn and in a diabetic
woman who presented with ocular redness, swelling and
corneal ulcer, leading to the diagnosis of infective keratitis
and conjunctivitis, which responded to topical antibiotics.
Drug susceptibilities
The MIC ranges of 20 antimicrobial agents for the nine non-
duplicate isolates (one isolate per person) of Gordonia spp.
are shown in Table 2. MIC ranges were similar in the two
species tested. All isolates showed high MIC values of nitro-
furantoin (£16–‡64 mg/L) and quinupristin–dalfopristin
(>2 mg/L). One isolate recovered from patient 4 (Table 1)
exhibited higher MICs of oxacillin (‡2 mg/L) vancomycin
(1 mg/L) and linezolid (2 mg/L) than the other eight isolates.
RAPD patterns
Distinct RAPD patterns, obtained using two random primers
were found among the 15 isolates. Identical RAPD patterns
were found for the three isolates (A1–3) from patient 1 and
the ﬁve isolates (H1–5) from patient 8.
Discussion
Gordonia spp. have occasionally been isolated as causative
agents of human infections, including CRBSI, endocarditis,
brain abscess and cutaneous infections [1–12]. Identiﬁcation
of Gordonia spp., as for most other Gram-positive bacilli, is
time-consuming, labour-intensive and often difﬁcult, owing to
frequently inconclusive results being obtained in biochemical
tests. The use of HPLC is required to determine the genus
level and separate Gordonia from the related genera Dietzia,
Corynebacterium, Rhodococcus and Tsukamurella. Furthermore,
identiﬁcation to the species level requires advanced molecu-
lar methods such as a comparison of 16S rRNA gene
sequencing data with those available in GenBank. Some
sequences in the GenBank database may be less reliable than
those found in other validated databases, especially in the
case of older sequences [13,14]. Recently, a PCR-RFLP analy-
sis of hsp65 has been reported to be useful for the identiﬁca-
tion of clinically signiﬁcant species and taxa of aerobic
actinomycetes [13,14].
Previous studies have shown that Gordonia spp. may be
misidentiﬁed as other gram-positive bacilli, such as Rhodococ-
cus or Nocardia spp. [9,11]. In this survey of 66 isolates pre-
viously identiﬁed as Rhodococcus spp. by conventional
microbiological culture and biochemical analysis, 15 isolates
were found to be Gordonia spp. by 16S rRNA gene sequenc-
ing. These ﬁndings suggest that Gordonia spp. may be under-
reported and that 16S rRNA gene sequencing is helpful for
accurate identiﬁcation.
Five patients in this series had Gordonia bacteraemia and
three of them had various underlying malignancies. Three of
these cases were caused by G. terrae and the other two cases
were caused by G. sputi. All of these patients had an initial pre-
sentation of fever, and no speciﬁc infection focus was found in
three of them. Despite the use of different combinations of
antimicrobial agents in three cases with invasive Gordonia infec-
tion, all of them responded to antibiotic therapy.
In previously reported cases [1–12], CRBSI was the most
common type of the invasive Gordonia infection and immuno-
compromised status was the major risk factor. Patient 1 of this
TABLE 2. Susceptibilities of nine nonduplicate isolates of
Gordonia spp. to 20 antimicrobial agents. by the broth
microdilution method
Agent
MIC range (mg/L)
Gordonia
terrae (n = 5)
Gordonia
sputi (n = 4)
Penicillin £0.125 £0.125
Ampicillin £2 £2
Amoxicillin–clavulanate £1/0.5 £1/0.5
Oxacillin £0.125 £0.125
Clindamycin 0.5–1 £0.25–0.5
Erythromycin £0.25 £0.25
Tetracycline £0.5 £0.5
Streptomycin £1000 £1000
Gentamicin £2 £2
Ciproﬂoxacin £0.5 £0.5
Levoﬂoxacin £1 £1
Moxiﬂoxacin £1 £1
Nitrofurantoin 32–64 £16–64
Chloramphenicol £1 £1
Trimethoprim–sulfamethoxazole £0.5/9.5 £0.5/9.5
Rifampin £0.5 £0.5
Vancomycin £0.5 £0.5–1
Teicoplanin £0.5 £0.5
Quinupristin–dalfopristin >2 >2
Linezolid £0.25 £0.25–2
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study suffered persistent G. terrae CRBSI despite antibiotic
treatment and this resolved after catheter removal. In
addition, antibiotic-lock therapy with systemic antibiotic treat-
ment successfully cleared the infection and rescued the Hick-
man catheter in patient 8, who had G. sputi CRBSI. This limited
experience might suggest that cases of CRBSI as a result of
Gordonia spp. should be treated with catheter removal to clear
the infection. As for antibiotic lock therapy, we cannot draw
any conclusion regarding the efﬁcacy for Gordonia CRBSI until
more clinical experience is accumulated.
SSTI as a result of Gordonia, such as breast abscess and
sternal wound infections, have occasionally been reported
[17–20]. All of the reported cases were caused by either
G. terrae or G. bronchialis and most of them required com-
bined therapy with prolonged antibiotic treatment and surgi-
cal debridement [17–20]. The two patients (patients 7 and 9)
with G. terrae-related SSTI reported in the present study
were immunocompetent and successfully cleared their infec-
tions after medical and surgical management. Thus, G. terrae
should be considered as one of the pathogens causing SSTI,
and surgical debridement might be crucial for the successful
treatment of this rare clinical entity. In the present series, a
newborn and a diabetic woman had G. sputi-related infective
keratitis and conjunctivitis, which responded to topical anti-
biotics. Our review of the literature found only one report
of ocular Gordonia infection [21].
A review of antibiotic susceptibility data on 24 clinical iso-
lates by Blaschke et al. [5] found that carbapenems, amino-
glycosides, linezolid and ﬂuoroquinolones showed good
activity against Gordonia spp., although the activity of ampicil-
lin, trimethoprim-sulfamethoxazole, clarithromycin and peni-
cillin was poor, with 56–70% of tested isolates showing
higher MICs. The present study found that the MICs of most
study agents for Gordonia were low, except in the case of ni-
trofurantoin and quinupristin–dalfopristin. Furthermore, the
MICs of amoxicillin/clavulanic acid, ciproﬂoxacin and vanco-
mycin for the Gordonia isolates were £1/0.5, £0.5, and
£0.5 mg/L, respectively, and the outcomes in patients treated
with these three antimicrobials were favourable. Because of
the various susceptibility testing methods used in different
studies and the limited number of cases tested, it is difﬁcult
to draw inferences about optimal antibiotic treatment [1–12].
RAPD pattern analysis-based arbitarily primed PCR has a
high discriminatory power for molecular typing and the pres-
ent study is the ﬁrst to report its use in the typing of Gordo-
nia spp. The analysis showed that isolates from different
patients had different patterns, indicating that they were
genetically unrelated and that nosocomial transmission had
not occurred. Second, multiple isolates from two patients
with persistent CRBSI had identical RAPD patterns, implying
incomplete treatment for an occult focus or persistent
carriage of the same bacteria.
In conclusion, infections caused by Gordonia spp. are difﬁ-
cult to diagnose in immunocompromised and immunocompe-
tent patients. The clinical manifestations are protean, and
include primary and secondary bacteraemia, soft tissue infec-
tion and infective keratitis. Accurate identiﬁcation with
molecular methods is required if these unusual pathogens
are to be detected. Further clinical and laboratory investiga-
tion of Gordonia spp. infections is needed to establish treat-
ment guidelines.
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